Thyroid Artery Embolization for the Treatment of Compressive Goiters.

Recruiting N/A Interventional Study
Thyroid Nodules
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
20 (estimated)
Sponsor
Université de Sherbrooke · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Very few studies have investigated TAE as a treatment for goiter with compressive symptoms. What is the efficacy and safety of TAE for the treatment of compressive goiters in a population ineligible for or refusing standard therapy? This is a prospective interventional cohort study that will allow us to standardize imaging by improving quality data collection and fellow-up to assess the efficacy o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient with compressive symptoms or significant tracheal or oesophageal compression at risk of causing symptoms attributed to a goiter AND * Ineligible for surgery/ablative treatments or preference for TAE over other treatments AND * TiRADS category 1, 2, 3 or 4 AND * Bethesd…
Contacts

Laurent Fradet, MD FRCSC

+1-819-346-1110

Laurent.Fradet@USherbrooke.ca

CONTACT